Giuseppe
Emeritus
[Source: Eurosurveillance, full text: (LINK). Abstract, edited.]
J Castilla (
)<SUP>1</SUP><SUP>,2</SUP>, I Mart?nez-Baz<SUP>1</SUP><SUP>,2</SUP>, V Mart?nez-Artola<SUP>3</SUP>, M Fernandez-Alonso<SUP>4</SUP>, G Reina<SUP>4</SUP>, M Guevara<SUP>1</SUP><SUP>,2</SUP>, M Garc?a Cenoz<SUP>1</SUP><SUP>,2</SUP>, F El?a<SUP>5</SUP>, N Alvarez<SUP>6</SUP>
Citation style for this article: Castilla J, Mart?nez-Baz I, Mart?nez-Artola V, Fernandez-Alonso M, Reina G, Guevara M, Garc?a Cenoz M, El?a F, Alvarez N. Early estimates of influenza vaccine effectiveness in Navarre, Spain: 2012/13 mid-season analysis. Euro Surveill. 2013;18(7)
ii=20404. Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20404
Date of submission: 01 February 2013 <HR>We present estimates of influenza vaccine effectiveness (VE) in Navarre, Spain, in the early 2012/13 season, which was dominated by influenza B. In a population-based cohort using electronic records from physicians, the adjusted VE in preventing influenza-like illness was 32% (95% confidence interval (CI): 15 to 46). In a nested test-negative case?control analysis the adjusted VE in preventing laboratory-confirmed influenza was 86% (95% CI: 45 to 96). These results suggest a high protective effect of the vaccine.
- ------
Eurosurveillance, Volume 18, Issue 7, 14 February 2013
Rapid communications
Early estimates of influenza vaccine effectiveness in Navarre, Spain: 2012/13 mid-season analysis
Rapid communications
Early estimates of influenza vaccine effectiveness in Navarre, Spain: 2012/13 mid-season analysis
J Castilla (
- Instituto de Salud P?blica de Navarra (Public Health Institute of Navarre), Pamplona, Spain
- Centro de Investigaci?n Biom?dica en Red de Epidemiolog?a y Salud P?blica (CIBERESP; Network of Biomedical Research Centers Epidemiology and Public Health), Spain
- Complejo Hospitalario de Navarra (Hospital Complex of Navarre), Pamplona, Spain
- Cl?nica Universidad de Navarra (University Clinic of Navarre), Pamplona, Spain
- Primary Healthcare Directorate, Navarre Health Service, Pamplona, Spain
- Servicio Navarro de Salud (Navarre Health Service), Pamplona, Spain
Citation style for this article: Castilla J, Mart?nez-Baz I, Mart?nez-Artola V, Fernandez-Alonso M, Reina G, Guevara M, Garc?a Cenoz M, El?a F, Alvarez N. Early estimates of influenza vaccine effectiveness in Navarre, Spain: 2012/13 mid-season analysis. Euro Surveill. 2013;18(7)
ii=20404. Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20404 Date of submission: 01 February 2013 <HR>We present estimates of influenza vaccine effectiveness (VE) in Navarre, Spain, in the early 2012/13 season, which was dominated by influenza B. In a population-based cohort using electronic records from physicians, the adjusted VE in preventing influenza-like illness was 32% (95% confidence interval (CI): 15 to 46). In a nested test-negative case?control analysis the adjusted VE in preventing laboratory-confirmed influenza was 86% (95% CI: 45 to 96). These results suggest a high protective effect of the vaccine.